.png){kind=spacer}
Systemic &
High-throughput
Drug Discovery
FluoSphera is the only company with a suite of systemic and high-throughput in vitro drug discovery solutions that reduce costs and increase speed and effectiveness.
A Powerful Offering for Drug Discovery
Integrated Discovery Product
Integrated Program of Systemic Drug Discovery
Selectivity
Product
Discovery of the most
selective therapies
Therapeutic
Index Product
Selection of drugs with the
best therapeutic index
System-Omics Product
Systemic biomarkers and
drug mode of action for the clinic
Translational
Product
Identification of the
most translatable species
Cost effective. Faster.
Improved drug discovery outcomes.
FluoSphera’s chip-free 3D cell culturing solutions mimic the natural physiology of the human body, its complex biology, and disease states, enabling researchers to study the human response to systemic drug delivery rapidly and precisely.
FluoSphera empowers its customers and partners to de-risk drug discovery
Benefits of Partnering with FluoSphera
Accelerated Drug Discovery
Multiplexing, high-throughput, modular technology allows for individual project customization for rapid evaluation of >1000 compounds with 28 simultaneous readouts.
Reduced Reliance on Animal Testing
Systemic Exposure recapitulates human first-pass liver Drug Metabolism and PharmacoKinetics (DMPK) allowing for early detection of drug systemic effects normally only detected in animal models or patients.
Reduced Pre-clinical Expenditure
Optimizes pre-clinical testing and animal model species selection, reducing unnecessary costs while enhancing the likelihood of clinical trial success.
Things move fast in drug discovery,
so don't get left behind.
Subscribe to our Investor Newsletter to keep up with FluoSphera’s milestones ahead of the next fundraising round
